Matthew L. Sherman - 02 Oct 2023 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc.

Role
EVP & Chief Medical Officer
Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
02 Oct 2023
Net transactions value
-$37,305
Form type
4
Filing time
04 Oct 2023, 16:05:11 UTC
Previous filing
23 Jun 2023
Next filing
31 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DCPH Common Stock Sale $37,305 -2,942 -3.4% $12.68 84,744 02 Oct 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was to cover tax liabilities in the vesting of restricted stock units.